ARCHIVES

PCORI Approves $54.8 Million For Clinical Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010

FDA Proposes New Nonclinical Lab Regs

November 26, 1976

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

ACS Awards Grants To Wisconsin, USC For Behavior Research

July 16, 1993

Opening Shots Fired In 10 Year Defense of Cancer Program, Launching Of Effort To Continue, Expand It

September 19, 1980